SG Americas Securities LLC Has $539,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SG Americas Securities LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 4,284 shares of the exchange traded fund’s stock after acquiring an additional 244 shares during the period. SG Americas Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $539,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Psagot Investment House Ltd. grew its holdings in SPDR S&P Biotech ETF by 173.7% in the 2nd quarter. Psagot Investment House Ltd. now owns 80,223 shares of the exchange traded fund’s stock valued at $10,862,000 after buying an additional 50,915 shares during the last quarter. Alexandria Capital LLC grew its holdings in SPDR S&P Biotech ETF by 1.8% in the 2nd quarter. Alexandria Capital LLC now owns 59,252 shares of the exchange traded fund’s stock valued at $8,023,000 after buying an additional 1,052 shares during the last quarter. Shay Capital LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $1,780,000. Hollow Brook Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Hollow Brook Wealth Management LLC now owns 7,755 shares of the exchange traded fund’s stock valued at $1,050,000 after buying an additional 122 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its holdings in SPDR S&P Biotech ETF by 4.0% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 106,867 shares of the exchange traded fund’s stock valued at $13,434,000 after buying an additional 4,072 shares during the last quarter.

XBI opened at $100.49 on Friday. The stock’s 50 day moving average price is $114.73 and its two-hundred day moving average price is $123.62. SPDR S&P Biotech ETF has a 12-month low of $95.77 and a 12-month high of $174.79.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Story: What is included in the gross domestic product?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.